Advertisement

Journal of Pharmaceutical Investigation

, Volume 45, Issue 1, pp 73–78 | Cite as

Laboratory scale production of injectable liposomes by using cell disruptor to avoid the probe sonication process

  • Soon-Seok Hong
  • Soo-Jeong LimEmail author
Regular Article

Abstract

Multilamellar vesicle (MLV)-type liposomes are promising carriers for hydrophobic drugs that need to be injected. In MLV preparation process, probe sonication step is often required to obtain liposomes fulfilling the mean particle size and polydispersity index (PI) requirements as an injectable lipid formulation. However, it is often limited by the risk of sample overheating. This study was undertaken to explore a possibility of using cell disruptor in the liposome preparation process as an alternative sonication method. Use of cell disruptor-type sonicator decreased the mean particle size and PI of liposomes much more effectively compared to conventional bath sonicators. The effectiveness of cell disruptor sonicator in decreasing the size and PI of liposomes was comparable to that of probe sonicator, particularly in the presence of a hydrophobic drug celecoxib. Sonication of liposomes by a cell disruptor sonicator produced celecoxib-loaded liposomes exhibiting 152 ± 9 nm mean particle size with a PI of 0.155, indicating a very homogenous and fine dispersion. Together with its proved efficacy in increasing the homogeneity, the advantage of cell disruptor sonicator includes the minimal exposure of liposome samples to heat, thereby providing an efficient method to prepare injectable liposomes at a laboratory scale.

Keywords

Cell disruptor Sonication Liposomes Multilamellar vesicles Poorly soluble drug 

Notes

Acknowledgments

All authors (S.-S. Hong and S.-J. Lim) declare that they have no conflict of interest. The article does not contain any studies with human and animal subjects performed by any of the authors. This work was supported by the Basic Science Research Foundation of Korea (KRF) funded by the Ministry of Education, Science and Technology (No. 2012R1A1A2042768).

References

  1. Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehour Y, Samiei M, Kouhi M, Nejati-Koshki K (2013) Liposome: classification, preparation, and application. Nanoscale Res Lett 8(1):102CrossRefPubMedCentralPubMedGoogle Scholar
  2. Basile L, Passirani C, Huynh NT, Bejaud J, Benoit JP, Puglisi G, Pignatello R (2012) Serum-stable, long-circulating paclitaxel-loaded colloidal carriers decorated with a new amphiphilic PEG derivative. Int J Pharm 426(2):231–238CrossRefPubMedGoogle Scholar
  3. Bhardwaj U, Burgess DJ (2010) Physicochemical properties of extruded and non-extruded liposomes containing the hydrophobic drug dexamethasone. Int J Pharm 388(1):181–190CrossRefPubMedGoogle Scholar
  4. Copeland RA, Pompliano DL, Meek TD (2006) Drug-target residence time and its implications for lead optimization. Nat Rev Drug Discov 5(9):730–739CrossRefPubMedGoogle Scholar
  5. Dickson D, Liu G, Li C, Tachiev G, Cai Y (2012) Dispersion and stability of bare hematite nanoparticles: effect of dispersion tools, nanoparticle concentration, humic acid and ionic strength. Sci Total Environ 419:170–177CrossRefPubMedGoogle Scholar
  6. Driscoll DF (2009) The pharmacopeial evolution of intralipid injectable emulsion in plastic containers: from a coarse to a fine dispersion. Int J Pharm 368(2):193–198CrossRefPubMedGoogle Scholar
  7. Elhissi AM, O’Neill MA, Roberts SA, Taylor KM (2006) A calorimetric study of dimyristoylphosphatidyl- choline phase transitions and steroid-liposome interactions for liposomes prepared by thin film and proliposome methods. Int J Pharm 320(1):124–130CrossRefPubMedGoogle Scholar
  8. Furumoto K, Yokoe J, Ogawara K, Amano S, Takaguchi M, Higaki K, Kai T, Kimura T (2007) Effect of coupling of albumin onto surface of PEG liposome on its in vivo disposition. Int J Pharm 329(1):110–116CrossRefPubMedGoogle Scholar
  9. Han HK, Kim YM, Lim SJ, Hong SS, Jung SG, Cho H, Lee W, Jin E (2011) Enhanced efficacy of TD53, a novel algicidal agent, against the harmful algae via the liposomal delivery system. Int J Pharm 405(2):137–141CrossRefPubMedGoogle Scholar
  10. Kang DI, Lee S, Lee JT, Sung BJ, Yoon JY, Kim JK, Chung J, Lim SJ (2011a) Preparation and in vitro evaluation of anti-VCAM-1-Fab-conjugated liposomes for the targeted delivery of the poorly water-soluble drug celecoxib. J Microencapsul 28(3):220–227CrossRefPubMedGoogle Scholar
  11. Kang SN, Lee E, Lee MK, Lim SJ (2011b) Preparation and evaluation of tributyrin emulsion as a potent anti-cancer agent against melanoma. Drug Deliv 18(2):143–149CrossRefPubMedGoogle Scholar
  12. Lee EH, Hong SS, Kim SH, Lee MK, Lim JS, Lim SJ (2014) Computed tomography-guided screening of surfactant effect on blood circulation time of emulsions: application to the design of an emulsion formulation for paclitaxel. Pharm Res 19 [Epub ahead of print]Google Scholar
  13. Mohammed AR, Weston N, Coombes AG, Fitzgerald M, Perrie Y (2004) Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. Int J Pharm 285(1):23–34CrossRefPubMedGoogle Scholar
  14. Qu G, Wu X, Yin L, Zhang C (2012) N-octyl-O-sulfate chitosan-modified liposomes for delivery of docetaxel: preparation, characterization, and pharmacokinetics. Biomed Pharmacother 66(1):46–51CrossRefPubMedGoogle Scholar
  15. Takatsuka J, Nakai M (2014) Replication of Mythimna separata entomopoxvirus in High Five™ cells and the construction of a recombinant. J Invertebr Pathol 118C:12–17CrossRefGoogle Scholar
  16. Thakur R, Das A, Chakraborty A (2014) The fate of anticancer drug, ellipticine in DPPC and DMPC liposomes upon interaction with HSA: a photophysical approach. J Photochem Photobiol B 130:122–131CrossRefPubMedGoogle Scholar
  17. Torchilin VP (2006) Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng 8:343–375CrossRefPubMedGoogle Scholar
  18. Vanniasinghe AS, Bender V, Manolios N (2009) The potential of liposomal drug delivery for the treatment of inflammatory arthritis. Semin Arthritis Rheum 39:182–196CrossRefPubMedGoogle Scholar
  19. Xu X, Khan MA, Burgess DJ (2012) Predicting hydrophilic drug encapsulation inside unilamellar liposomes. Int J Pharm 423(2):410–418CrossRefPubMedGoogle Scholar
  20. Zielinska K, Wilk KA, Jezierski A, Jesionowski T (2008) Microstructure and structural transition in microemulsions stabilized by aldonamide-type surfactants. J Colloid Interface Sci 321(2):408–417CrossRefPubMedGoogle Scholar

Copyright information

© The Korean Society of Pharmaceutical Sciences and Technology 2014

Authors and Affiliations

  1. 1.Department of Bioscience and BioengineeringSejong UniversitySeoulRebublic of Korea

Personalised recommendations